Stocks Comparison
Airsculpt Technologies vs Basel Medical: revenue, profit, margins and growth compared
Airsculpt Technologies brought in $151.8M of revenue in fiscal 2025, Basel Medical $8.9M in fiscal 2025. Airsculpt Technologies kept -7.7% of its revenue as net profit, Basel Medical -94.0%. Free cash flow was $692K at Airsculpt Technologies and -$3.6M at Basel Medical.
Side by side, latest fiscal year
| AIRS | BMGL | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (June 30, 2025) |
| Revenue | $151.8M | $8.9M |
| Revenue growth | -15.8% | n/a |
| Net income | -$11.7M | -$8.4M |
| Net margin | -7.7% | -94.0% |
| Free cash flow | $692K | -$3.6M |
| Free cash flow margin | 0.5% | -40.6% |
| Earnings per share (diluted) | -$0.19 | -$0.45 |
| Cash | $8.4M | $2.4M |
| Debt | $56M | n/a |
| Price to earnings | n/a | n/a |
| Market value | $141.3M | $5.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #275 of 646 · Health care | #481 of 646 · Health care |
Over the years
AIRS $151.8MBMGL $8.9M
AIRS -$11.7MBMGL -$8.4M
AIRS -7.7%BMGL -94.0%
AIRS -15.8%BMGL
AIRS $692KBMGL -$3.6M
Questions about Airsculpt Technologies and Basel Medical
Which is bigger by revenue, Airsculpt Technologies or Basel Medical?
Airsculpt Technologies is bigger by revenue: $151.8M in fiscal 2025, against $8.9M for Basel Medical in fiscal 2025.
Which keeps more of its revenue as profit, Airsculpt Technologies or Basel Medical?
Airsculpt Technologies had a net margin of -7.7% in fiscal 2025; Basel Medical had -94.0% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.